In this CME Outfitters livestream symposium, expert faculty will identify the immunometabolic mechanisms by which visceral and mesenteric adipose tissue contribute to IBD disease activity, therapeutic attenuation, and surgical risk in people with IBD and obesity. Learners will be shown how to apply appropriate, validated methods to systematically identify and characterize adiposity in people with IBD during routine gastroenterology encounters, including recognition of peoples at highest risk based on adiposity distribution. Faculty will model development of an individualized treatment plan for a patient with IBD and obesity that integrates weight management strategies and addresses the safety and appropriate use of GLP-1 RAs in this population.
This event is neither sponsored by nor endorsed by ACG.